Neutral
Johnson & Johnson's stock remains steady at $270.22 following Q2 earnings beat.
In the past 24 hours, Johnson & Johnson's stock has maintained its position at $270.22, reflecting investor confidence after the company reported strong Q2 earnings. The stock's performance is also supported by positive analyst sentiment and recent strategic developments.
Key points
- Johnson & Johnson's stock holds steady at $270.22 after Q2 earnings beat.
- Analysts maintain a 'Moderate Buy' consensus rating with an average price target of $274.13.
- The company declared a quarterly dividend of $1.34 per share, yielding approximately 2.0%.
- Recent strategic developments, including FDA approvals and pipeline advancements, support the stock's current valuation.
Sources
- Johnson & Johnson stock gains on July quarter and guidanceAD HOC NEWS · September 18, 2026
- Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.4% - Here's What HappenedMarketBeat · August 27, 2026
- Johnson & Johnson (NYSE:JNJ) Shares Up 1.1% - What's Next?MarketBeat · August 24, 2026
- Johnson & Johnson reports Q4 and Full-Year 2025 resultsJohnson & Johnson Investor Relations · January 21, 2026
AI-generated from public news sources. Not financial advice.
